170 related articles for article (PubMed ID: 37752569)
21. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
[TBL] [Abstract][Full Text] [Related]
22. Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma.
Miao Y; Wang X; Lai Y; Huang Y; Yin H; Meng X; Liu H; Hou R; Lin W; Zhang X; Zhang X; Chai BC; Zhang F; Guo L; Yang S
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37264968
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
24. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
25. Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.
Xuan X; Li S; Lou X; Zheng X; Li Y; Wang F; Gao Y; Zhang H; He H; Zeng Q
Mol Biol Rep; 2015 May; 42(5):907-15. PubMed ID: 25407307
[TBL] [Abstract][Full Text] [Related]
26. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract][Full Text] [Related]
27. BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy.
Yang W; Cheng B; Chen P; Sun X; Wen Z; Cheng Y
Cell Death Dis; 2022 Nov; 13(11):984. PubMed ID: 36418890
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
29. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
30. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
[TBL] [Abstract][Full Text] [Related]
31. STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α.
Zhang C; Yang X; Zhang Q; Guo Q; He J; Qin Q; Zhu H; Liu J; Zhan L; Lu J; Liu Z; Xu L; Ma J; Dai S; Cheng H; Sun X
Tumour Biol; 2014 Oct; 35(10):9793-9. PubMed ID: 24981247
[TBL] [Abstract][Full Text] [Related]
32. HIF-1alpha mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinoma.
Turcotte S; Desrosiers RR; Béliveau R
J Cell Sci; 2003 Jun; 116(Pt 11):2247-60. PubMed ID: 12697836
[TBL] [Abstract][Full Text] [Related]
33. Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway.
Luo H; Yang Z; Zhang Q; Shao L; Wei S; Liu R; Li Z; Geng Y; Li C; Wang X
Front Public Health; 2020; 8():579705. PubMed ID: 33330321
[TBL] [Abstract][Full Text] [Related]
34. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
35. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
[TBL] [Abstract][Full Text] [Related]
36. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
[No Abstract] [Full Text] [Related]
37. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
[TBL] [Abstract][Full Text] [Related]
38. HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway.
Tang K; Toyozumi T; Murakami K; Sakata H; Kano M; Endo S; Matsumoto Y; Suito H; Takahashi M; Sekino N; Otsuka R; Kinoshita K; Hirasawa S; Hu J; Uesato M; Hayano K; Matsubara H
Br J Cancer; 2022 Aug; 127(3):474-487. PubMed ID: 35484214
[TBL] [Abstract][Full Text] [Related]
39. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
40. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
